Bringing Focus to Autoimmune Diseases

Diagnosing patients with Autoimmune Disorders is a serious process. Manhattan Labs understands what patients go through in order to receive an accurate diagnosis. Manhattan Labs is using new technology to optimize testing panels that may result in earlier detection of various autoimmune diseases.


Manhattan Labs Sponsors the Arthritis Walkarthritis walk

On May 19, 2013 Manhattan Labs co-sponsored the Arthritis Foundation’s NYC Arthritis Walk to support the 50 million Americans who are effected by Arthritis every day. According to the Arthritis Foundation, all proceeds from the walk assisted in the prevention, control, and cure of arthritis and its related diseases. For more information about the 2013 walk please click here click here.

AW images




Signature Tests and Panels By Focus

ANA Testing

Manhattan Labs is one of the progressive reference laboratories offering ANA screening by IFA utilizing HEp-2 cells. Nova Lite HEp-2® cells are optimized to display proteins in the correct conformational structure to help ensure that even hard to identify patterns are detected. Barcoded slides assist in enabling seamless laboratory workflow by tracking patient data from sample preparation to result. This test allows for the detection of many autoimmune diseases.

Antiphospholipid Antibody Syndrome (APS)

APS Testing

According to the APS diagnostic criteria, both Anticardiolipin (ACA) and Beta-2 Glycoprotein 1 (B2GP1) IgG and/or IgM are necessary to aid in the diagnosis of APS. In addition to offering both the QUANTA Lite ACA and QUANTA Lite B2GP1 assays of the IgG and IgM isotype, Manhattan Labs offers the QUANTA Lite ACA and B2GP1 IgA tests.  In cases of secondary APS, IgA antibodies are more prevalent, especially in the African American population.  APS is often a complex disease to accurately diagnose. By offering a comprehensive panel of assays, a clearer clinical picture can be obtained.


CCP3.1 Testing (Rheumatoid Arthritis)

Manhattan Labs offers the QUANTA Lite® CCP3.1 test, a unique ACPA assay consistent with the updated diagnostic criteria from the American College of Rheumatology. This test is FDA cleared as an aid in the diagnosis of rheumatoid arthritis (RA), including early RA, which makes it ideal for use in detecting RA before irreversible damage occurs.


Celiac Testing
The number of patients being diagnosed with Celiac disease is increasing each year. Manhattan Labs recognizes the importance of an accurate and rapid diagnosis for long-term patient well-being. ML offers physicians and their patients a testing menu for Celiac disease including tissue transglutaminase (h-tTG), IgG/IgA, and Deamidated Gliadin Peptide (DGP), IgG/IgA to allow for increased sensitivity and specificity as well as serological assessment of a gluten free diet.

For more information about our specialty offerings please visit our Specialities Page.

Ask Us a Question

  • Please read our Notice of Privacy Practices before sending any personal information over the internet.

  • This field is for validation purposes and should be left unchanged.